[ad_1]
The experts who attended the Consultative Meeting of the Central Pharmacists Review Committee on the AstraZeneca Corona 19 vaccine license held at the Ministry of Food and Drug Safety in Cheongju City, Chungcheongbuk-do on the afternoon of 4, are reviewing the meeting data. Cheongju = Yonhap News
AstraZeneca’s new vaccine against coronavirus infection (Corona 19), which will be supplied during this month, will be vaccinated first in nursing hospitals and nursing facilities, even if it is not aimed at people over 65 years of age. Quarantine authorities have decided to keep vaccination priorities as planned regardless of whether the AstraZeneca vaccine can be vaccinated after age 65, and they are making a list of targets.
According to the Corona 19 Vaccination Response Promotion Team (hereinafter, the Promotion Team) on the 7th, the list of people who will receive the AstraZeneca Corona 19 vaccine in hospitals and nursing facilities will be confirmed on the 19th of this month. Based on this, in the fourth week of this month, the required number of vaccinations will be assigned to each hospital and facility. A promotion team official said: “If 750,000 AstraZeneca vaccines come in, we will inoculate nursing hospitals and nursing facilities first.”
Experts who advised on the COVID-19 vaccine licensing from the Ministry of Food and Drug Safety were unable to conclude whether to allow the AstraZeneca vaccine to be targeted at people 65 and older despite the ‘marathon gathering’ on 4 If the Ministry of Food and Drug Safety restricts vaccines over 65 in Korea, as in many European countries, the existing plan of quarantine authorities is expected to prioritize vaccines in hospitals and nursing facilities it will be inevitable.
However, the advocacy team maintains the policy of “to reduce the mortality rate, priority is given to hospitals and nursing facilities.” An official from the advocacy team explained: “It is impossible to shake the vaccination plan during implementation, and even if some patients do not fit in, the facility itself must be protected.” Under the existing plan, hospitals and nursing facilities will receive priority vaccinations, but it is said that the KFDA or the Korea Centers for Disease Control and Prevention will decide whether to match the total number of people or just those under 64 years. depending on whether or not vaccination of the elderly is allowed. If those over 65 are excluded this time, the plan is to resume vaccination as soon as possible future vaccines are available.
A total of 750,000 people are eligible for vaccination in hospitals and nursing facilities, according to estimates by the advocacy team. If you are not older than 65, the vaccine will stay. The remaining vaccines are passed on to a total of 500,000 corona first responders19, including △ high-risk medical institutions such as general hospitals, △ epidemiological researchers and others, the next priority in the existing vaccination plan. The advocacy team is also compiling its list through the Health Insurance Review and Evaluation Service and its affiliated organizations.
According to this vaccination schedule, the promotion team receives a list of residents of hospitals and nursing facilities from the National Health Insurance Service, verifies each hospital and the competent health center, and is proceeding with the procedure to obtain consent. individual. If the list is confirmed before the 19th, the vaccine will be shipped directly to the nursing hospitals where the medical staff work, and the vaccine will be delivered with separate vaccination staff through the public health center to the unstaffed nursing facilities doctor.
Pfizer’s vaccine, which will arrive this month through global vaccine joint purchasing organization ‘Cobox Facility’, is also suitable for medical staff (50,000) treating Corona 19 patients as planned. An official from the advocacy team said: “The list of medical personnel who will receive the Pfizer vaccine this month is already specified.
Earlier, quarantine authorities announced that around 60,000 Pfizer vaccines and 750,000 AstraZeneca vaccines will be supplied to Korea this month. In the case of the AstraZeneca vaccine, controversy has also arisen in Korea, as European countries restrict vaccines for the elderly over 65, saying that data from clinical trials is insufficient. The experts in charge of consulting the Ministry of Food and Drug Safety issued the final judgment to the Korea Centers for Disease Control and Prevention.
Lim So-hyung reporter [email protected]
Subscribe to the Hankook Ilbo News Naver channel
Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo
[ad_2]
